Enter your login e-mail to the account
Search
Search parameters
Search results
- The first symptoms of multiple sclerosis and the importance of early treatment
Doc. MUDr. Vladimír Donáth, PhD.
(5/2017, Interdisciplinary consilium ) - TAKAYASU´S ARTERITIS
prof. MUDr. Viera Štvrtinová, CSc.
(1/2008, Topic ) - ANKYLOSING SPONDYLITIS – NEWS IN THERAPY
prof. MUDr. Jozef Rovenský, DrSc., FRCP, MUDr. Daniel Žlnay, CSc., MUDr. Martin Žlnay
(1/2008, Topic ) - Allergic rhinitis – actual immunological perspective
doc. MUDr. Martin Hrubiško, PhD.
(1/2015, Review articles )
- MULTIPLE SCLEROSIS AND DEPRESSION
doc. MUDr. Eva Havrdová, CSc., MUDr. Zdena Čechová
(5/2005, Review articles )
- Glatiramer acetate: long-term immunomodulatory therapy in multiple sclerosis – safety, efficacy, adherence and persistence assesment
MUDr. Olga Zapletalová
(2/2016, Review articles ) - Imunopatogeneze roztroušené sklerózy
doc. RNDr. Jan Krejsek, CSc., MUDr. Otakar Kopecký, CSc. , MUDr. Radomír Taláb, CSc.
(5/2002, Main topic ) - New trends in physiotherapy of people with multiple sclerosis
PhDr. Kamila Řasová, Ph.D.
(6/2013, From the boundary of neurology ) - MuSK antibody positive myasthenia gravis – our experience
doc. MUDr. Peter Špalek, PhD., MUDr. Ivan Martinka, PhD., MUDr. Štefan Kečkeš
(2/2021, Main topic ) - The role of B lymphocytes in the immunopathogenesis and treatment of multiple sclerosis
prof. MUDr. Ľubomír Lisý, DrSc.
(3/2024, Informations ) - Biological therapy by Ocrelizumab (antiCD20) is surprisingly clinically effective in multiple sclerosis patients
Prof. RNDr. Jan Krejsek, CSc.
(6/2017, From the boundary of neurology ) - Immunopathogenesis of coronavirus SARS-CoV-2 infection with respect to the multiple sclerosis
prof. RNDr. Jan Krejsek, CSc.
(3/2021, From the boundary of neurology ) - Periferní neuropatie u dětí
MUDr. Josef Kraus, CSc. , MUDr. Ivana Perníková, Marie Brožová
(3/2018, Main topic ) - Varianty akutní polyradikuloneuritidy
doc. MUDr. Edvard Ehler, CSc.
(3/2018, Main topic ) - Ocrelizumab is dampening the harm inflammation in patients with multiple sclerosis with little impact on protective immunity
prof. RNDr. Jan Krejsek, CSc.
(3/2020, From the boundary of neurology ) - Biologics targeting CD20 molecule on B cells in the therapy of multiple sclerosis patients
Prof. RNDr. Jan Krejsek, CSc.
(6/2022, From the boundary of neurology )
- Topical immunomodulators in the treatment of atopic dermatitis
prof. MUDr. Jagienka Jautová, PhD., MBA, MUDr. Janette Baloghová, PhD.
(3/2009, Drugs & drug classes ) - CHRONIC ABDOMINAL PAIN IN CHILDREN
MUDr. Vladimír Volf, Ph.D.
(3/2006, Review articles )
- BIOLOGICALS IN THE TREATMENT OF SEVERE FORMS OF PSORIASIS
MUDr. Martin Tichý, Ph.D.,, doc. MUDr. Dagmar Ditrichová, CSc.
(3-4/2007, Review articles ) - Quo Vadis in the antifungal treatment of gynecological problems at the beginning of the third millennium ?
doc. RNDr. Vladimír Buchta, CSc., PharmDr. Petr Jílek, CSc., doc. MUDr. Jiří Špaček, Ph.D., MUDr. Jan Kestřánek, MUDr. Vojtěch Matula
(3/2011, Interdisciplinary consilium ) - Autoimmune skin diseases I. Vitiligo, alopecia areata, psoriasis
doc. MUDr. Dušan Buchvald, CSc.
(1/2012, Topic of the year ) - View of clinical immunology on targeted therapy of psoriasis
doc. MUDr. Martin Hrubiško, PhD.
(1/2012, Interdisciplinary consilium ) - Atopic eczema from the perspective of an allergist
MUDr. Martin Fuchs
(3/2014, Interdisciplinary consilium )
- Microcirculation in intestinal mucosa and its conextion to IBD
MUDr. Petronela Bušíková, PhD., doc. MUDr. Ján Porubský, CSc.
(3-4/2012, Review articles )